Allen S. Yang - Publications

Affiliations: 
University of Southern California, Los Angeles, CA, United States 

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Byun HM, Eshaghian S, Douer D, Trent J, Garcia-Manero G, Bhatia R, Siegmund K, Yang AS. Impact of Chromosomal Rearrangement upon DNA Methylation Patterns in Leukemia. Open Medicine (Warsaw, Poland). 12: 76-85. PMID 28730166 DOI: 10.1515/med-2017-0014  0.744
2015 Yang AS, Yang BJ. The failure of epigenetic combination therapy for cancer and what it might be telling us about DNA methylation inhibitors. Epigenomics. PMID 26698294 DOI: 10.2217/epi.15.94  0.491
2012 Byun HM, Heo K, Mitchell KJ, Yang AS. Mono-allelic retrotransposon insertion addresses epigenetic transcriptional repression in human genome. Journal of Biomedical Science. 19: 13. PMID 22300442 DOI: 10.1186/1423-0127-19-13  0.643
2012 Zhu ZZ, Hou L, Bollati V, Tarantini L, Marinelli B, Cantone L, Yang AS, Vokonas P, Lissowska J, Fustinoni S, Pesatori AC, Bonzini M, Apostoli P, Costa G, Bertazzi PA, et al. Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysis. International Journal of Epidemiology. 41: 126-39. PMID 20846947 DOI: 10.1093/ije/dyq154  0.661
2011 Koh Y, Kim DY, Park SH, Byun HM, Kim I, Yoon SS, Kim BK, Park E, Yang AS, Park S. Increased BCR promoter DNA methylation status strongly correlates with favorable response to imatinib in chronic myeloid leukemia patients. Oncology Letters. 2: 181-187. PMID 22870150 DOI: 10.3892/ol.2010.208  0.732
2011 Choi SH, Heo K, Byun HM, An W, Lu W, Yang AS. Identification of preferential target sites for human DNA methyltransferases. Nucleic Acids Research. 39: 104-18. PMID 20841325 DOI: 10.1093/Nar/Gkq774  0.753
2010 Cowan LA, Talwar S, Yang AS. Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors. Epigenomics. 2: 71-86. PMID 22122748 DOI: 10.2217/epi.09.44  0.428
2010 Bernstein I, Byun HM, Mohrbacher A, Douer D, Gorospe G, Hergesheimer J, Groshen S, O'Connell C, Yang AS. A phase I biological study of azacitidine (Vidaza™) to determine the optimal dose to inhibit DNA methylation. Epigenetics : Official Journal of the Dna Methylation Society. 5: 750-7. PMID 20861661 DOI: 10.4161/Epi.5.8.13105  0.697
2010 Wolff EM, Byun HM, Han HF, Sharma S, Nichols PW, Siegmund KD, Yang AS, Jones PA, Liang G. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. Plos Genetics. 6: e1000917. PMID 20421991 DOI: 10.1371/Journal.Pgen.1000917  0.581
2009 Byun HM, Siegmund KD, Pan F, Weisenberger DJ, Kanel G, Laird PW, Yang AS. Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patterns. Human Molecular Genetics. 18: 4808-17. PMID 19776032 DOI: 10.1093/Hmg/Ddp445  0.761
2009 Jeong S, Liang G, Sharma S, Lin JC, Choi SH, Han H, Yoo CB, Egger G, Yang AS, Jones PA. Selective anchoring of DNA methyltransferases 3A and 3B to nucleosomes containing methylated DNA. Molecular and Cellular Biology. 29: 5366-76. PMID 19620278 DOI: 10.1128/Mcb.00484-09  0.548
2009 Fandy TE, Herman JG, Kerns P, Jiemjit A, Sugar EA, Choi SH, Yang AS, Aucott T, Dauses T, Odchimar-Reissig R, Licht J, McConnell MJ, Nasrallah C, Kim MK, Zhang W, et al. Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies. Blood. 114: 2764-73. PMID 19546476 DOI: 10.1182/Blood-2009-02-203547  0.439
2009 Breton CV, Byun HM, Wenten M, Pan F, Yang A, Gilliland FD. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. American Journal of Respiratory and Critical Care Medicine. 180: 462-7. PMID 19498054 DOI: 10.1164/Rccm.200901-0135Oc  0.695
2009 Choi SH, Worswick S, Byun HM, Shear T, Soussa JC, Wolff EM, Douer D, Garcia-Manero G, Liang G, Yang AS. Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer. International Journal of Cancer. Journal International Du Cancer. 125: 723-9. PMID 19437537 DOI: 10.1002/Ijc.24384  0.757
2009 Aparicio A, North B, Barske L, Wang X, Bollati V, Weisenberger D, Yoo C, Tannir N, Horne E, Groshen S, Jones P, Yang A, Issa JP. LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors. Epigenetics. 4: 176-84. PMID 19421002 DOI: 10.4161/Epi.4.3.8694  0.541
2008 Yoo CB, Chuang JC, Byun HM, Egger G, Yang AS, Dubeau L, Long T, Laird PW, Marquez VE, Jones PA. Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in mice. Cancer Prevention Research (Philadelphia, Pa.). 1: 233-40. PMID 19138966 DOI: 10.1158/1940-6207.Capr-07-0008  0.658
2008 Byun HM, Choi SH, Laird PW, Trinh B, Siddiqui MA, Marquez VE, Yang AS. 2'-Deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine: a novel inhibitor of DNA methyltransferase that requires activation by human carboxylesterase 1. Cancer Letters. 266: 238-48. PMID 18499340 DOI: 10.1016/J.Canlet.2008.02.069  0.681
2008 Heo K, Kim H, Choi SH, Choi J, Kim K, Gu J, Lieber MR, Yang AS, An W. FACT-mediated exchange of histone variant H2AX regulated by phosphorylation of H2AX and ADP-ribosylation of Spt16. Molecular Cell. 30: 86-97. PMID 18406329 DOI: 10.1016/J.Molcel.2008.02.029  0.404
2007 Houshdaran S, Cortessis VK, Siegmund K, Yang A, Laird PW, Sokol RZ. Widespread epigenetic abnormalities suggest a broad DNA methylation erasure defect in abnormal human sperm. Plos One. 2: e1289. PMID 18074014 DOI: 10.1371/Journal.Pone.0001289  0.567
2007 Byun HM, Wong HL, Birnstein EA, Wolff EM, Liang G, Yang AS. Examination of IGF2 and H19 loss of imprinting in bladder cancer. Cancer Research. 67: 10753-8. PMID 18006818 DOI: 10.1158/0008-5472.Can-07-0329  0.736
2007 Choi SH, Byun HM, Kwan JM, Issa JP, Yang AS. Hydroxycarbamide in combination with azacitidine or decitabine is antagonistic on DNA methylation inhibition. British Journal of Haematology. 138: 616-23. PMID 17686055 DOI: 10.1111/J.1365-2141.2007.06707.X  0.732
2007 Chu MW, Siegmund KD, Eckstam CL, Kim JY, Yang AS, Kanel GC, Tavaré S, Shibata D. Lack of increases in methylation at three CpG-rich genomic loci in non-mitotic adult tissues during aging. Bmc Medical Genetics. 8: 50. PMID 17672908 DOI: 10.1186/1471-2350-8-50  0.44
2007 Qin T, Youssef EM, Jelinek J, Chen R, Yang AS, Garcia-Manero G, Issa JP. Effect of cytarabine and decitabine in combination in human leukemic cell lines. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 4225-32. PMID 17634552 DOI: 10.1158/1078-0432.Ccr-06-2762  0.338
2007 Estécio MR, Gharibyan V, Shen L, Ibrahim AE, Doshi K, He R, Jelinek J, Yang AS, Yan PS, Huang TH, Tajara EH, Issa JP. LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. Plos One. 2: e399. PMID 17476321 DOI: 10.1371/Journal.Pone.0000399  0.422
2007 Bollati V, Baccarelli A, Hou L, Bonzini M, Fustinoni S, Cavallo D, Byun HM, Jiang J, Marinelli B, Pesatori AC, Bertazzi PA, Yang AS. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Research. 67: 876-80. PMID 17283117 DOI: 10.1158/0008-5472.CAN-06-2995  0.74
2006 Wong HL, Byun HM, Kwan JM, Campan M, Ingles SA, Laird PW, Yang AS. Rapid and quantitative method of allele-specific DNA methylation analysis. Biotechniques. 41: 734-9. PMID 17191619 DOI: 10.2144/000112305  0.713
2006 Yang AS, Doshi KD, Choi SW, Mason JB, Mannari RK, Gharybian V, Luna R, Rashid A, Shen L, Estecio MR, Kantarjian HM, Garcia-Manero G, Issa JP. DNA methylation changes after 5-aza-2'-deoxycytidine therapy in patients with leukemia. Cancer Research. 66: 5495-503. PMID 16707479 DOI: 10.1158/0008-5472.CAN-05-2385  0.487
2005 Chuang JC, Yoo CB, Kwan JM, Li TW, Liang G, Yang AS, Jones PA. Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine. Molecular Cancer Therapeutics. 4: 1515-20. PMID 16227400 DOI: 10.1158/1535-7163.Mct-05-0172  0.589
2004 Yang AS, Estécio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Research. 32: e38. PMID 14973332 DOI: 10.1093/nar/gnh032  0.607
Show low-probability matches.